THE ROLE OF PCSK9 INHIBITION IN ACHIEVING XS- LPNP TARGETING INDICATORS IN PATIENTS WITH IBS AND TYPE 2 DIABETES

Authors

  • Muminova Anjela Yuryevna 1 ะะฒั‚ะพั€

Abstract

The aim of the study is to evaluate the effectiveness of incorporating inclisiran into combined hypolipidemic therapy to achieve target levels of LDL-C in patients with ischemic heart disease and type 2 diabetes mellitus

Downloads

Published

2026-06-15

Issue

Vol. 2 No. 6 (2026)

Section

ะกั‚ะฐั‚ัŒะธ

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

Muminova , A. (2026). THE ROLE OF PCSK9 INHIBITION IN ACHIEVING XS- LPNP TARGETING INDICATORS IN PATIENTS WITH IBS AND TYPE 2 DIABETES. International Conference on Health & Technology, 2(6), 58-59. https://uniconflix.com/index.php/ICHT/article/view/5313